Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2000Blood

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

BDBerno DankbarUniversity Hospital MünsterTPTeresa PadróVascular MedicineRLRegine LeoUniversity of Münster

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dankbar et al. (2000) studied this question.

synapsesocial.com/papers/6a9341d86b34f0e4f05fae65https://doi.org/10.1182/blood.v95.8.2630.008k05_2630_2636
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival1975 · 3,057 citations
  2. 2Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells1997 · 28 citations
  3. 3Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B1996 · 572 citations
  4. 4Vascular Endothelial Growth Factor, a Possible Paracrine Growth Factor in Human Acute Myeloid Leukemia1997 · 449 citations